These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 11236926

  • 1. Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues.
    Murata R, Overgaard J, Horsman MR.
    Int J Radiat Biol; 2001 Feb; 77(2):195-204. PubMed ID: 11236926
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: a comparative assessment using MRI and MRS.
    Breidahl T, Nielsen FU, Stødkilde-Jørgensen H, Maxwell RJ, Horsman MR.
    Acta Oncol; 2006 Feb; 45(3):306-16. PubMed ID: 16644574
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination of vascular targeting agents with thermal or radiation therapy.
    Horsman MR, Murata R.
    Int J Radiat Oncol Biol Phys; 2002 Dec 01; 54(5):1518-23. PubMed ID: 12459380
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid.
    Cao Z, Joseph WR, Browne WL, Mountjoy KG, Palmer BD, Baguley BC, Ching LM.
    Br J Cancer; 1999 May 01; 80(5-6):716-23. PubMed ID: 10360649
    [Abstract] [Full Text] [Related]

  • 10. Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R, Overgaard J, Horsman MR.
    Int J Hyperthermia; 2001 May 01; 17(6):508-19. PubMed ID: 11719967
    [Abstract] [Full Text] [Related]

  • 11. Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy.
    Siemann DW, Mercer E, Lepler S, Rojiani AM.
    Int J Cancer; 2002 May 01; 99(1):1-6. PubMed ID: 11948484
    [Abstract] [Full Text] [Related]

  • 12. Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid.
    Murata R, Siemann DW, Overgaard J, Horsman MR.
    Radiat Res; 2001 Nov 01; 156(5 Pt 1):503-9. PubMed ID: 11604063
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid.
    Cliffe S, Taylor ML, Rutland M, Baguley BC, Hill RP, Wilson WR.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):373-7. PubMed ID: 8195036
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.
    Joseph WR, Cao Z, Mountjoy KG, Marshall ES, Baguley BC, Ching LM.
    Cancer Res; 1999 Feb 01; 59(3):633-8. PubMed ID: 9973211
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS.
    Beauregard DA, Pedley RB, Hill SA, Brindle KM.
    NMR Biomed; 2002 Apr 01; 15(2):99-105. PubMed ID: 11870905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.